Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
NEKTAR THERAPEUTICS Add to My Watchlist (NSDQ: NKTR) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Nektar 11.71 +0.31 (+2.72%) 611,817
201 Industrial Road
San Carlos, CA 94070 US
(650) 631-3100
(650) 631-3150 fax
www.nektar.com
CEO Howard W. Robin
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US6402681083
CIK Number 906709
NAICS Code 325412
Business Summary
A clinical-stage biopharmaceutical company, which is engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
Number of Employees 338
Share Fundamentals
Market Cap 1.09B
Shares Outstanding 93.20M
Float 92.01M
Short Interest 6.32M
Financial Strength
Revenue (TTM) $61,275,000
Earnings (TTM) -$18,061,000
Quick Ratio 5.7:1
Current Ratio 6:1
Total Debt/Equity 2.21:1
Profitability
Gross Margin 75.7%
EBITDA Margin N/A
Profit Margin -32.4%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs